These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 19284360)

  • 1. The use of cephalosporins for gonorrhea: the impending problem of resistance.
    Barry PM; Klausner JD
    Expert Opin Pharmacother; 2009 Mar; 10(4):555-77. PubMed ID: 19284360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence and Spread of Cephalosporin-Resistant Neisseria gonorrhoeae with Mosaic penA Alleles, South Korea, 2012-2017.
    Lee H; Suh YH; Lee S; Kim YK; Han MS; Bae HG; Unemo M; Lee K
    Emerg Infect Dis; 2019 Mar; 25(3):416-424. PubMed ID: 30789143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure.
    Unemo M; Golparian D; Nicholas R; Ohnishi M; Gallay A; Sednaoui P
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1273-80. PubMed ID: 22155830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of decreased susceptibility and resistance to extended-spectrum cephalosporins in Neisseria gonorrhoeae in Korea.
    Lee H; Unemo M; Kim HJ; Seo Y; Lee K; Chong Y
    J Antimicrob Chemother; 2015 Sep; 70(9):2536-42. PubMed ID: 26084303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neisseria gonorrhoeae and extended-spectrum cephalosporins in California: surveillance and molecular detection of mosaic penA.
    Gose S; Nguyen D; Lowenberg D; Samuel M; Bauer H; Pandori M
    BMC Infect Dis; 2013 Dec; 13():570. PubMed ID: 24305088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure.
    Lewis DA; Sriruttan C; Müller EE; Golparian D; Gumede L; Fick D; de Wet J; Maseko V; Coetzee J; Unemo M
    J Antimicrob Chemother; 2013 Jun; 68(6):1267-70. PubMed ID: 23416957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro selection of Neisseria gonorrhoeae mutants with elevated MIC values and increased resistance to cephalosporins.
    Johnson SR; Grad Y; Ganakammal SR; Burroughs M; Frace M; Lipsitch M; Weil R; Trees D
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6986-9. PubMed ID: 25199775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Susceptibilities to Carbapenems and Faropenem Against Cephalosporin-Resistant Neisseria gonorrhoeae Clinical Isolates with penA Mosaic Alleles.
    Hiyama Y; Takahashi S; Sato T; Shinagawa M; Fukushima Y; Nakajima C; Suzuki Y; Masumori N; Yokota SI
    Microb Drug Resist; 2019 Apr; 25(3):427-433. PubMed ID: 30676251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
    Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E
    MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility and penicillin-binding protein 1 and 2 mutations in Neisseria gonorrhoeae isolated from male urethritis in Sapporo, Japan.
    Takahashi S; Kurimura Y; Hashimoto J; Uehara T; Hiyama Y; Iwasawa A; Nishimura M; Sunaoshi K; Takeda K; Suzuki N; Tsukamoto T
    J Infect Chemother; 2013 Feb; 19(1):50-6. PubMed ID: 22797875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome sequencing of a Neisseria gonorrhoeae isolate of a successful international clone with decreased susceptibility and resistance to extended-spectrum cephalosporins.
    Hess D; Wu A; Golparian D; Esmaili S; Pandori W; Sena E; Klausner JD; Barry P; Unemo M; Pandori M
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5633-41. PubMed ID: 22908152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of amino acids conferring high-level resistance to expanded-spectrum cephalosporins in the penA gene from Neisseria gonorrhoeae strain H041.
    Tomberg J; Unemo M; Ohnishi M; Davies C; Nicholas RA
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3029-36. PubMed ID: 23587946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neisseria gonorrhoeae antimicrobial susceptibility in Barcelona: penA, ponA, mtrR, and porB mutations and NG-MAST sequence types associated with decreased susceptibility to cephalosporins.
    Serra-Pladevall J; Barberá MJ; Rodriguez S; Bartolomé-Comas R; Roig G; Juvé R; Andreu A
    Eur J Clin Microbiol Infect Dis; 2016 Sep; 35(9):1549-56. PubMed ID: 27255221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An insight into the drug resistance profile & mechanism of drug resistance in Neisseria gonorrhoeae.
    Patel AL; Chaudhry U; Sachdev D; Sachdeva PN; Bala M; Saluja D
    Indian J Med Res; 2011 Oct; 134(4):419-31. PubMed ID: 22089602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic Epidemiology of Gonococcal Resistance to Extended-Spectrum Cephalosporins, Macrolides, and Fluoroquinolones in the United States, 2000-2013.
    Grad YH; Harris SR; Kirkcaldy RD; Green AG; Marks DS; Bentley SD; Trees D; Lipsitch M
    J Infect Dis; 2016 Nov; 214(10):1579-1587. PubMed ID: 27638945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of target population on nonculture-based detection of markers of Neisseria gonorrhoeae antimicrobial resistance.
    Goire N; Freeman K; Lambert SB; Nimmo GR; Limnios AE; Lahra MM; Nissen MD; Sloots TP; Whiley DM
    Sex Health; 2012 Nov; 9(5):422-9. PubMed ID: 23036167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial resistance for Neisseria gonorrhoeae in the United States, 1988 to 2003: the spread of fluoroquinolone resistance.
    Wang SA; Harvey AB; Conner SM; Zaidi AA; Knapp JS; Whittington WL; del Rio C; Judson FN; Holmes KK
    Ann Intern Med; 2007 Jul; 147(2):81-8. PubMed ID: 17638718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of Recent Genomic Evolution in Gonococcal Strains With Decreased Susceptibility to Cephalosporins or Azithromycin in the United States, 2014-2016.
    Thomas JC; Seby S; Abrams AJ; Cartee J; Lucking S; Vidyaprakash E; Schmerer M; Pham CD; Hong J; Torrone E; Cyr SS; Shafer WM; Bernstein K; Kersh EN; Gernert KM;
    J Infect Dis; 2019 Jun; 220(2):294-305. PubMed ID: 30788502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from Hefei (2014-2015): genetic characteristics of antimicrobial resistance.
    Jiang FX; Lan Q; Le WJ; Su XH
    BMC Infect Dis; 2017 May; 17(1):366. PubMed ID: 28545411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance of Neisseria gonorrhoeae isolates to beta-lactam antibiotics (benzylpenicillin and ceftriaxone) in Russia, 2015-2017.
    Shaskolskiy B; Dementieva E; Kandinov I; Filippova M; Petrova N; Plakhova X; Chestkov A; Kubanov A; Deryabin D; Gryadunov D
    PLoS One; 2019; 14(7):e0220339. PubMed ID: 31344102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.